CPhI Worldwide 2018 – Madrid, 9 – 11 October 2018

15 May 2018

Zambon Group SA: Zcube launches the third edition of Open Accelerator, the programme for projects in the Central Nervous System and Respiratory areas

14 May 2018

Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States

8 May 2018

NovellusDx announces it has completed an equity financing of $6 million

3 May 2018

Cerbios-Pharma Successfully Passes a General FDA cGMP Inspection

30 April 2018

Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced

24 April 2018

1 Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy

24 April 2018

Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States

24 April 2018

Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018

24 April 2018

Cerbios-Pharma SA – Enterococcus faecium SF68®: a model for efficacy and safety for Pharmaceutical Probiotics

20 April 2018